Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions

OBJECTIVES: High dose of intravenous sulfamethoxazole and trimethoprim (co-trimoxazole) is often used in immunocompromised patients for the treatment of Pneumocystis jiroveci pneumonia. Current manufacturer’s dilution recommendation for intravenous co-trimoxazole (1:25 v/v) requires the administrati...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Eur J Hosp Pharm
Glavni autori: Khaleel, Israa, Zaidi, Syed Tabish R, Shastri, Madhur D, Eapen, Mathew Suji, Ming, Long Chiau, Wanandy, Troy, Patel, Rahul P
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6319416/
https://ncbi.nlm.nih.gov/pubmed/31157078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2017-001225
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items